Jonathon Unwin
Stock Analyst at Barclays
(0.25)
# 4,635
Out of 5,126 analysts
70
Total ratings
27%
Success rate
-15%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: YPSN Ypsomed Holding AG | Reiterated: Buy | CHF 480.00 → CHF 522.00 | CHF 414.00 | +26.09% | 11 | Nov 12, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Reiterated: Sell | kr 29.00 | kr 42.00 | -30.95% | 15 | Oct 23, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €27.00 | €34.40 | -21.51% | 12 | Oct 16, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 182p | 205p | -11.31% | 10 | Sep 28, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Upgraded: Buy | €16.00 → €27.00 | €24.50 | +10.20% | 13 | Aug 18, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Sell | €17.00 → €25.00 | €31.92 | -21.68% | 9 | Jul 29, 2026 |
Ypsomed Holding AG
Nov 12, 2026
Reiterated: Buy
Price Target: CHF 480.00 → CHF 522.00
Current: CHF 414.00
Upside: +26.09%
Vimian Group AB (publ)
Oct 23, 2026
Reiterated: Sell
Price Target: kr 29.00
Current: kr 42.00
Upside: -30.95%
Carl Zeiss Meditec AG
Oct 16, 2026
Reiterated: Hold
Price Target: €27.00
Current: €34.40
Upside: -21.51%
Oxford Nanopore Technologies plc
Sep 28, 2026
Reiterated: Buy
Price Target: 182p
Current: 205p
Upside: -11.31%
SCHOTT Pharma AG & Co. KGaA
Aug 18, 2026
Upgraded: Buy
Price Target: €16.00 → €27.00
Current: €24.50
Upside: +10.20%
Gerresheimer AG
Jul 29, 2026
Reiterated: Sell
Price Target: €17.00 → €25.00
Current: €31.92
Upside: -21.68%